tiprankstipranks
Curis Inc (CRIS)
NASDAQ:CRIS

Curis (CRIS) Income Statement

1,343 Followers

Curis Income Statement

Last quarter (Q3 2023), Curis's total revenue was $2.83M, an increase of 0.28% from the same quarter last year. In Q3, Curis's net income was $-12.18M. See Curis’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 7.33M$ 10.16M$ 10.65M$ 10.84M$ 10.00M$ 10.43M
Cost of Revenue
--$ -533.00K$ 534.00K$ 503.00K$ 563.00K
Gross Profit
$ 7.33M$ 9.90M$ 10.65M$ 10.30M$ 9.50M$ 9.87M
Operating Expense
$ 43.46M$ -62.92M$ 52.71M$ 35.20M$ 33.86M$ 39.20M
Operating Income
$ -36.13M$ -53.02M$ -42.06M$ -24.90M$ -24.36M$ -29.33M
Net Non Operating Interest Income Expense
$ 1.69M$ -3.65M$ -4.26M$ -5.03M$ -4.23M$ -3.24M
Other Income Expense
$ 1.06M$ 3.65M$ -890.00K$ 22.00K$ -3.55M-
Pretax Income
$ -35.70M$ -56.67M$ -45.44M$ -29.91M$ -32.14M$ -32.58M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -35.70M$ -56.67M$ -45.44M$ -29.91M$ -32.14M$ -32.58M
Basic EPS
$ -2.37$ 0.61$ -0.50$ -0.61$ -0.97$ -0.98
Diluted EPS
$ -2.37$ 0.61$ -0.50$ -0.61$ -0.97$ -0.98
Basic Average Shares
$ 199.02M$ 93.39M$ 91.57M$ 48.67M$ 33.18M$ 33.12M
Diluted Average Shares
$ 199.02M$ 93.39M$ 91.57M$ 48.67M$ 33.18M$ 33.12M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
---$ 695.00K$ 580.00K$ 553.00K
Total Expenses
$ 43.46M$ 63.18M$ 52.18M$ 35.73M$ 34.36M$ 39.76M
Net Income From Continuing And Discontinued Operation
$ -35.74M$ -56.67M$ -45.44M$ -29.91M$ -32.14M$ -32.58M
Normalized Income
$ -19.07M$ -44.77M-$ -29.91M$ -28.65M$ -32.58M
Interest Expense
---$ 5.09M$ 4.85M$ 3.93M
EBIT
$ -35.70M$ -56.67M$ -45.44M$ -24.81M$ -27.30M$ -28.65M
EBITDA
$ -36.55M$ -56.12M$ -43.88M$ -24.67M$ -27.17M$ -28.47M
Currency in USD

Curis Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis